Computational Scientist​/Senior Computational Scientist

Switchpoint Bio is decoding the molecular switchpoints that drive human health and disease. The choices our cells make — which genes to activate, how to respond to environment and exposure, when to mount immune defenses — are governed by epigenetic mechanisms. We bring together genomics, epigenomics, and AI to turn epigenetic biology into decision-grade evidence for drug discovery and clinical decision-making.

The opportunity. Epigenetics is how cells record genetics, aging, environment, and exposure across a lifetime — and it shapes nearly every major area of human disease. Our flagship programs focus on autoimmune conditions and cancer today, but the same mechanisms underlie cardiovascular, metabolic, and neurodegenerative disease. Together, these touch billions of lives — yet most treatments are still chosen by trial and error.

We're building the platform that makes these mechanisms visible — and the evidence base that turns it into better drugs, earlier diagnoses, and treatments matched to the person, not the population.

Founded by pioneers in single-cell biology, epigenetics, and genomics, we operate across Helsinki and Boston. We're a small founding team in the earliest days — building not just a platform, but a company and a culture from scratch.

We hire builders. People who take ownership, move fast, and thrive when the problem is bigger than the playbook. If you want to join the first wave of hires at a company tackling some of the biggest open questions in human biology — and shape what it becomes — this is that moment. We're AI-native from day one, and we hire people who already work that way.

We have an established team building machine learning models and infrastructure. For this role, we're looking for the scientist who brings the deep domain knowledge to point these tools towards new biological opportunities.

As a Computational Scientist you'll be the biological and analytical lead on our multiomic data: designing how we integrate genomics, epigenomics, transcriptomics, and proteomics with biobank cohorts, health registries, and exposure data, and interpreting what it means for disease mechanism and drug discovery. You'll work closely with our ML scientists — you shape the scientific questions, the study design, the ground truth, and the biological validation;

together you turn high-dimensional molecular data into evidence the company can act on.

• Lead the design and analysis of multimodal data integration — combining molecular data (genomics, epigenomics, transcriptomics, proteomics), single-cell and biobank-scale cohorts, health registries, and lifestyle/exposure data into coherent, interpretable analyses.
• Bring domain judgment to modeling: define the biological questions, choose the right cohorts and comparisons, engineer biologically meaningful features, and decide what "good" looks like for immune cell-type identification, disease classification, and treatment-response prediction.
• Own biological interpretation and validation — connect molecular signals to mechanisms (immune regulation, epigenetic control, disease pathways), and separate real biology from batch effects, technical artifacts, and confounding.
• Read the frontier of the genomics, epigenomics and immunology literature independently, judge what's credible, and recommend what we should build or adopt next.
• Partner with the ML scientist to turn scientific questions into models and evals, and translate model output back into decision-grade biological evidence.
• Work with wet-lab and clinical collaborators to shape assay and study design so the resulting data is analyzable, well-controlled, and answers the question we actually care about.

• Multiomic integration framework — establish how we bring molecular, cohort, registry, and exposure data together, with the QC, harmonization, and confounder handling that make cross-cohort analysis trustworthy.
• Immune cell-type and disease signatures — define and validate the biological ground truth behind our immune cell-type identification and disease classifiers, so the models the team ships reflect real biology.
• Mechanis…